Conexus Bio
- Biotech or pharma, therapeutic R&D
- Financial, legal, consulting
Since its foundation in March 2022, Conexus （previous Sinogen） has focused mostly on assisting China local biopharma/pharmaceutical companies in expanding their business development capabilities and licensing out their assets to partners outside of China. The Conexus primary team was built by a number of experienced BD specialists and key team members are based in Shanghai, Boston, and San Francisco. The Conexus team has extensive resources and relationships with biopharma/pharmaceutical companies in the US and Europe.
Since we establishment, Conexus has worked with around 20 China local biopharmaceutical companies and has closed 2 deals worth >$2B USD.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}